Achilles Therapeutics plc
ACHL · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $86 | $95 | $112 | $132 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $22 | $18 | $16 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $3 | $4 |
| Total Curr. Assets | $112 | $118 | $131 | $146 |
| Property Plant & Equip (Net) | $9 | $11 | $12 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $11 | $13 | $14 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $123 | $131 | $146 | $161 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $3 | $6 |
| Short-Term Debt | $4 | $4 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$3 | $0 |
| Other Curr. Liab. | $11 | $7 | $7 | $8 |
| Total Curr. Liab. | $18 | $14 | $14 | $17 |
| LT Debt | $0 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $1 | $1 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $4 | $5 |
| Total Liabilities | $20 | $16 | $15 | $19 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$308 | -$289 | -$272 | -$260 |
| AOCI | -$8 | -$14 | -$14 | -$13 |
| Other Equity | $419 | $418 | $417 | $415 |
| Total Equity | $103 | $115 | $130 | $142 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $123 | $131 | $146 | $161 |
| Net Debt | -$82 | -$91 | -$108 | -$127 |